Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 19, 2023 (Week 33)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2023 †Cum YTD 2022 †
U.S. Residents, excluding U.S. Territories 14,425 34,834 902,384 1,083,142
New England 178 1,650 24,055 33,368
Connecticut - 430 1,155 7,822
Maine 55 77 1,867 2,049
Massachusetts - 709 15,463 17,892
New Hampshire 38 82 1,680 1,857
Rhode Island 85 694 3,059 2,954
Vermont - 37 831 794
Middle Atlantic 2,257 4,218 120,384 121,912
New Jersey 522 788 21,451 21,079
New York (excluding New York City) 930 1,032 26,151 25,063
New York City - 1,457 38,864 40,794
Pennsylvania 805 1,233 33,918 34,976
East North Central 1,889 5,790 119,447 180,509
Illinois 114 1,811 31,190 45,240
Indiana 299 836 17,886 21,477
Michigan 312 975 20,507 27,066
Ohio 726 2,294 34,026 70,129
Wisconsin 438 561 15,838 16,597
West North Central 901 2,153 57,825 64,638
Iowa 167 334 8,567 9,377
Kansas 66 325 5,963 8,991
Minnesota 111 497 13,514 14,142
Missouri 557 745 20,128 20,439
Nebraska - 220 4,903 6,165
North Dakota - 92 1,763 2,267
South Dakota - 125 2,987 3,257
South Atlantic 3,284 7,248 207,709 215,935
Delaware - 210 3,492 3,317
District of Columbia - 191 4,101 5,134
Florida 1,806 2,786 71,488 67,346
Georgia 23 1,597 42,665 46,627
Maryland U NC U U
North Carolina 9 1,443 35,566 41,447
South Carolina 688 766 21,195 23,047
Virginia 730 976 26,513 26,129
West Virginia 28 104 2,689 2,888
East South Central 1,017 2,450 61,907 70,792
Alabama 610 972 21,753 19,520
Kentucky 400 555 10,373 11,481
Mississippi 7 483 10,246 15,121
Tennessee - 1,094 19,535 24,670
West South Central 667 5,323 100,786 161,608
Arkansas 204 804 10,244 22,934
Louisiana 441 794 22,419 23,418
Oklahoma 22 451 6,759 13,180
Texas - 3,399 61,364 102,076
Mountain 1,275 2,523 65,201 74,739
Arizona 556 918 25,304 26,285
Colorado 460 766 16,501 16,537
Idaho - 155 3,426 3,605
Montana 27 100 1,899 2,634
Nevada 8 367 4,667 10,298
New Mexico - 257 5,338 7,151
Utah 204 253 7,044 7,134
Wyoming 20 54 1,022 1,095
Pacific 2,957 5,049 145,070 159,641
Alaska 64 121 2,574 3,471
California 2,217 4,112 120,245 123,742
Hawaii - 142 - 3,489
Oregon 286 383 9,598 10,047
Washington 390 635 12,653 18,892
U.S. Territories - 124 1,138 2,950
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 124 1,138 2,950
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 7 38 90
Total 14,425 34,934 903,560 1,086,182
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2022 and 2023 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.